Showing 34,803 results

Filters
PrEP science

First pills-versus-gel trial finds US women prefer oral PrEP

News
2 March 2011
Religion & faith

Swaziland: Thabile Xaba, 'I Can Take the ARVs Now if I Like But I Must Consult the Ancestors'

Editor's pick
IRIN Plus News
2 March 2011
Men who have sex with men (MSM)

New Report: World's Premier AIDS Event Neglects Populations Most at Risk for HIV

Editor's pick
CNBC
2 March 2011
UK health services

UK: NHS reform could see GP surgeries on stock market

Editor's pick
The Guardian
2 March 2011
Epidemiology

Thousands of people with HIV protest India-EU trade deal restricting access to cheap drugs

Editor's pick
Los Angeles Times
2 March 2011
Epidemiology

Thousands of people with HIV protest India-EU trade deal restricting access to cheap drugs

Editor's pick
2 March 2011
New & experimental HIV treatments

Virostatics' VS411 Phase 2a trial results against HIV presented at 18th CROI

Editor's pick
The Medical News
2 March 2011
Bone & joint problems

Does immune reconstitution contribute to ART-related bone loss?

News
2 March 2011
PrEP science

New data from PrEP study shed light on adherence, bone mineral loss and resistance

News
2 March 2011
New & experimental HIV treatments

Tobira reports on PK, safety, of new CCR5 inhibitor cenicriviroc

Editor's pick
Bioportfolio
2 March 2011
Side effects

Abacavir not linked to increased risk of heart attack, reports US FDA

News
2 March 2011
Ageing & HIV

Decreased limb muscle and increased abdominal fat linked to higher mortality in people with HIV

News
2 March 2011
New & experimental HIV treatments

Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells In Gut Mucosa Of Chronically HIV Infected Immunological Non-Responder Patients

Editor's pick
HIV / AIDS News From Medical News Today
2 March 2011
How HIV works

NIH-funded study shows early brain effects of HIV in mouse model

Editor's pick
EurekAlert
2 March 2011
Adherence

Intensive adherence counseling with HIV treatment improves patient outcomes

Editor's pick
Eurekalert HIV
1 March 2011
Treatment for women

Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

Editor's pick
The BodyPro
1 March 2011
Neurological & cognitive problems

Previous Syphilis Infection Might Cause Poorer Brain Function for People With HIV

Editor's pick
AIDSmeds.com
1 March 2011
Starting treatment

3-year results on Merck’s ISENTRESS® (raltegravir): sustained viral load suppression and tolerability

Editor's pick
Business Week
1 March 2011
Finance & funding

Winners and losers in the UK aid review

Editor's pick
The Guardian
1 March 2011
HIV treatment

Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against Abbott

Editor's pick
Bloomberg
1 March 2011
Viral load

Treatment monitoring: no clear benefit to adding viral load to CD4 or clinical symptoms in Thailand and Africa

News
1 March 2011
Finance & funding

UK aid budget refocuses 'on areas of greatest need'

Editor's pick
The Guardian
1 March 2011
New & experimental HIV treatments

Attachment inhibitor BMS-663068 potent and well-tolerated in early study

News
1 March 2011

Choose your runner

News
1 March 2011